Sale

Nootropics Market

Global Nootropics Market Size, Analysis, Forecast: By Type: Over the Counter, Prescription; By Indications: Productivity and Study, Socializing, Exercise and Health, Wellbeing, Others; By Dosage Form: Tablets, Capsules, Others; By Route of Administration; By End User; By Distribution Channel; Regional Analysis; Supplier Landscape; 2024-2032

Global Nootropics Market Outlook

The global nootropics market attained USD 3.01 billion in 2023. The global nootropics industry is expected to grow at a CAGR of 14.6% in the forecast period of 2024-2032 to attain USD 10.28 billion by 2032.

 

Global Nootropics Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America holds a Leading Share of the Global Market of Nootropics

North America has the highest number of nootropics consumers regionally and holds the major market share of nootropics. The U.S. Food and Drug Administration has classified non-prescription nootropics product under the Generally Regarded as Safe (GRAS) category, thereby easing market expansion. Hence, it is the home of the largest market players in the nootropics industry. Consumption of multi-vitamin tablets for improving functional abilities is fairly common among the population of this region. High awareness for cognitive health, the rise of self-directed buyers, and a growing population are some of the factors that drive the market dominance of North America. The Asia Pacific is expected to be the fastest growing market in the forecast period. Countries such as China and India have a great history of cognitive based natural drugs. Foreign investment in collaboration with regional players holds immense potential for the growth of the nootropics industry.

 

Nootropics: Market Segmentation

Nootropics are drugs or supplements that claim to improve cognitive function, specifically executive functions, memory, creativity, or motivation, in healthy individuals. These have been in the market for several decades, such as caffeine and multivitamins - substances approved by FDA as dietary supplements and classified as GRAS (generally regarded as safe). Currently, these products are being marketed and sold to academic and professional overachievers to augment their brain functions.

 

Global Nootropics Market By Application

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The market is bifurcated by type into:

  • Prescription
  • OTC

The market is segmented on the basis of distribution channel into:

  • Online
  • Offline

The market is segregated on the basis of application into:

  • Mood and Depression
  • Longevity and Anti-Ageing
  • Sleep and Recovery
  • Memory Enhancement
  • Attention and Focus
  • Anxiety
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Nootropics Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rising Internet Penetration to Aid the Market Growth of Nootropics

Due to a highly competitive and challenging work environment, the market for brain boosters has witnessed a rise and is expected to grow in the forecast period. The rising demand for improved decision making in the sports industry and growing awareness with respect to mental health are also boosting the rise of the market for nootropics. Due to increasing awareness, rising disposable incomes, and increased demand for productivity, the market is expected to grow rapidly in emerging countries such as China and India. As cognitive enhancers made from natural and herbal substances have already been common in these areas historically, mergers between foreign and local companies are expected to push the market for nootropics in these areas forward. However, on the flip side, various side effects, addiction, lack of awareness, the stigma around visiting psychiatrists and neurologists in developing countries might impede the growth of the nootropics industry.

 

Key Industry Players in the Global Nootropics Market

The report gives a detailed analysis of the following key players in the global nootropics market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Purelife Bioscience Co., Ltd.
  • UCB S.A.
  • HVMN Inc.
  • Gaia Herbs, Inc.
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Indications
  • Dosage Form
  • Route of Administration
  • End User
  • Distribution Channel
  • Region
Breakup by Type
  • Over the Counter
  • Prescription
Breakup by Indications
  • Productivity and Study
  • Socializing
  • Exercise and Health
  • Wellbeing
  • Others
Breakup by Dosage Form
  • Tablets
  • Capsules
  • Injections
  • Others
Breakup by Route of Administration
  • Oral
  • Parenteral
  • Others
Breakup by End User
  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others
Breakup by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • AstraZeneca
  • Johnson & Johnson Private Limited
  • Cephalon A/S
  • Reckitt Benckiser Group PLC
  • Onnit Labs, Inc.
  • Mental Mojo, LLC
  • Noocube
  • Opti-Nutra Ltd.
  • TruBrain
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Nootropics Market Overview 

    3.1    Global Nootropics Market Historical Value (2017-2023) 
    3.2    Global Nootropics Market Forecast Value (2024-2032)
4    Global Nootropics Market Landscape
    4.1    Global Nootropics Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Nootropics Product Landscape
        4.2.1    Analysis by Type
        4.2.2    Analysis by Indication
        4.2.3    Analysis by End User
5    Global Nootropics Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Nootropics Market Segmentation 
    6.1    Global Nootropics Market by Type
        6.1.1    Market Overview
        6.1.2    Over the Counter
            6.1.2.1    L-theanine
            6.1.2.2    Creatine
            6.1.2.3    Phenotropil
            6.1.2.4    Others
        6.1.3    Prescription
            6.1.3.1    Ritalin
            6.1.3.2    Adderall
            6.1.3.3    Provigil
            6.1.3.4    Piracetam
            6.1.3.5    Others
    6.2    Global Nootropics Market by Indications 
        6.2.1    Market Overview
        6.2.2    Productivity and Study
        6.2.3    Socializing
        6.2.4    Exercise and Health
        6.2.5    Wellbeing
        6.2.6    Others
    6.3    Global Nootropics Market by Dosage Form 
        6.3.1    Market Overview
        6.3.2    Tablets
        6.3.3    Capsules
        6.3.4    Injections
        6.3.5    Others
    6.4    Global Nootropics Market by Route of Administration 
        6.4.1    Market Overview
        6.4.2    Oral
        6.4.3    Parenteral
        6.4.4    Others
    6.5    Global Nootropics Market by End User
        6.5.1    Market Overview
        6.5.2    Hospitals
        6.5.3    Specialty Clinics
        6.5.4    Homecare
        6.5.5    Others
    6.6    Global Nootropics Market by Distribution Channel
        6.6.1    Market Overview
        6.6.2    Hospital Pharmacy
        6.6.3    Retail Pharmacy
        6.6.4    Online Pharmacy
        6.6.5    Others
    6.7    Global Nootropics Market by Region
        6.7.1    Market Overview
        6.7.2    North America 
        6.7.3    Europe
        6.7.4    Asia Pacific
        6.7.5    Latin America
        6.7.6    Middle East and Africa
7    North America Nootropics Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Nootropics Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Nootropics Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Nootropics Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Nootropics Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Clinical Trials Analysis
    14.1     Analysis by Trial Registration Year
    14.2    Analysis by Trial Status
    14.3    Analysis by Trial Phase
    14.4    Analysis by Therapeutic Area
    14.5    Analysis by Geography
15    Funding and Investment Analysis
    15.1    Analysis by Funding Instances
    15.2    Analysis by Type of Funding
    15.3    Analysis by Funding Amount
    15.4    Analysis by Leading Players
    15.5    Analysis by Leading Investors
    15.6    Analysis by Geography
16    Partnership and Collaborations Analysis
    16.1    Analysis by Partnership Instances
    16.2    Analysis by Type of Partnership
    16.3    Analysis by Leading Players
    16.4    Analysis by Geography
17    Regulatory Framework
    17.1    Regulatory Overview
        17.1.1    US FDA
        17.1.2    EU EMA
        17.1.3    INDIA CDSCO
        17.1.4    JAPAN PMDA
        17.1.5    Others
18    Supplier Landscape
    18.1    Pfizer Inc.
        18.1.1    Financial Analysis
        18.1.2    Product Portfolio
        18.1.3    Demographic Reach and Achievements
        18.1.4    Mergers and Acquisitions
        18.1.5    Certifications
    18.2    GlaxoSmithKline plc
        18.2.1    Financial Analysis
        18.2.2    Product Portfolio
        18.2.3    Demographic Reach and Achievements
        18.2.4    Mergers and Acquisitions
        18.2.5    Certifications
    18.3    Novartis AG
        18.3.1    Financial Analysis
        18.3.2    Product Portfolio
        18.3.3    Demographic Reach and Achievements
        18.3.4    Mergers and Acquisitions
        18.3.5    Certifications
    18.4    Mylan N.V.
        18.4.1    Financial Analysis
        18.4.2    Product Portfolio
        18.4.3    Demographic Reach and Achievements
        18.4.4    Mergers and Acquisitions
        18.4.5    Certifications
    18.5    Teva Pharmaceutical Industries Ltd.
        18.5.1    Financial Analysis
        18.5.2    Product Portfolio
        18.5.3    Demographic Reach and Achievements
        18.5.4    Mergers and Acquisitions
        18.5.5    Certifications
    18.6    Sanofi
        18.6.1    Financial Analysis
        18.6.2    Product Portfolio
        18.6.3    Demographic Reach and Achievements
        18.6.4    Mergers and Acquisitions
        18.6.5    Certifications
    18.7    AstraZeneca
        18.7.1    Financial Analysis
        18.7.2    Product Portfolio
        18.7.3    Demographic Reach and Achievements
        18.7.4    Mergers and Acquisitions
        18.7.5    Certifications
    18.8    Johnson & Johnson Private Limited
        18.8.1    Financial Analysis
        18.8.2    Product Portfolio
        18.8.3    Demographic Reach and Achievements
        18.8.4    Mergers and Acquisitions
        18.8.5    Certifications
    18.9    Cephalon A/S
        18.9.1    Financial Analysis
        18.9.2    Product Portfolio
        18.9.3    Demographic Reach and Achievements
        18.9.4    Mergers and Acquisitions
        18.9.5    Certifications
    18.10    Reckitt Benckiser Group PLC
        18.10.1    Financial Analysis
        18.10.2    Product Portfolio
        18.10.3    Demographic Reach and Achievements
        18.10.4    Mergers and Acquisitions
        18.10.5    Certifications
    18.11    Onnit Labs, Inc.
        18.11.1    Financial Analysis
        18.11.2    Product Portfolio
        18.11.3    Demographic Reach and Achievements
        18.11.4    Mergers and Acquisitions
        18.11.5    Certifications
    18.12    Mental Mojo, LLC
        18.12.1    Financial Analysis
        18.12.2    Product Portfolio
        18.12.3    Demographic Reach and Achievements
        18.12.4    Mergers and Acquisitions
        18.12.5    Certifications
    18.13    Noocube
        18.13.1    Financial Analysis
        18.13.2    Product Portfolio
        18.13.3    Demographic Reach and Achievements
        18.13.4    Mergers and Acquisitions
        18.13.5    Certifications
    18.14    Opti-Nutra Ltd.
        18.14.1    Financial Analysis
        18.14.2    Product Portfolio
        18.14.3    Demographic Reach and Achievements
        18.14.4    Mergers and Acquisitions
        18.14.5    Certifications
    18.15    TruBrain
        18.15.1    Financial Analysis
        18.15.2    Product Portfolio
        18.15.3    Demographic Reach and Achievements
        18.15.4    Mergers and Acquisitions
        18.15.5    Certifications
19    Global Nootropics Market - Distribution Model (Additional Insight)
    19.1    Overview 
    19.2    Potential Distributors 
    19.3    Key Parameters for Distribution Partner Assessment 
20    Key Opinion Leaders (KOL) Insights (Additional Insight)
21    Company Competitiveness Analysis (Additional Insight)

    21.1    Very Small Companies
    21.2    Small Companies
    21.3    Mid-Sized Companies
    21.4    Large Companies
    21.5    Very Large Companies
22    Payment Methods (Additional Insight)
    22.1    Government Funded
    22.2    Private Insurance
    22.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

In 2023, the global nootropics market attained a value of nearly USD 3.01 billion.

The market is projected to grow at a CAGR of 14.6% between 2024 and 2032.

The major drivers of the market include the increasing awareness, rising disposable incomes, increased demand for productivity, rise of self-directed buyers, growing population, and foreign investment.

The rising demand for improved decision-making in the sports industry and growing awareness with respect to mental health are the key industry trends propelling the market's growth.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

Prescription and OTC are the types of nootropics in the market.

The market is segmented on the basis of distribution channels into online and offline.

Based on applications, the industry is divided into mood and depression, longevity and anti-ageing, sleep and recovery, memory enhancement, attention and focus, and anxiety, among others.

The major players in the industry are Purelife Bioscience Co., Ltd., UCB S.A., HVMN Inc., and Gaia Herbs, Inc., among others.

Analyst Review

The global nootropics market attained a value of nearly USD 3.01 billion in 2023, driven by the rising demand for improved decision-making in the sports industry. Aided by rising disposable incomes and growing awareness with respect to mental health, the market is expected to witness further growth in the forecast period of 2024-2032, growing at a CAGR of 14.6%.

EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Prescription and OTC are the types of nootropics in the market. The market is segmented on the basis of distribution channels into online and offline. Based on applications, the industry is divided into mood and depression, longevity and anti-ageing, sleep and recovery, memory enhancement, attention and focus, and anxiety, among others. The major regional markets for the nootropics are North America, Europe, the Asia Pacific, Latin America, the Middle East and Africa. The major players in the industry are Purelife Bioscience Co., Ltd., UCB S.A., HVMN Inc., and Gaia Herbs, Inc., among others.

EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER